Literature DB >> 2478321

Specificity of monoclonal antibodies in local passive immunization against Streptococcus mutans.

J K Ma1, M Hunjan, R Smith, T Lehner.   

Abstract

Local oral passive immunization in human subjects with a monoclonal antibody (MoAb) raised against the 185-kD antigen I/II from S. mutans significantly reduced or prevented oral colonization of an exogenous strain of the organism. In subjects sham-immunized with either saline or an unrelated MoAb, however, significantly greater proportions of S. mutans persisted for a longer duration than in those immunized with the specific anti-streptococcal MoAb. Recolonization of indigenous S. mutans after this organism was reduced to undetectable levels by an antimicrobial agent has also been completely prevented with specific MoAb. Indeed, S. mutans was not detected for a period of over 1 year, as compared with recolonization within 10-82 days in the control subjects. The specificity of MoAb in preventing colonization of the streptococci was studied with four MoAb. This revealed that: (1) the sub-class of antibody is not an essential factor, as both MoAb Guy's 1 and 13 prevented colonization, although Guy's 1 is an IgG2a and Guy's 13 is an IgG1 class of antibody; (2) serotype specificity is important, as MoAb Guy's 9, which only recognizes S. sobrinus (serotypes d and g), does not prevent colonisation by S. mutans (serotype c); (3) neither protein nor carbohydrate nature of the putative adhesin was a determining factor, because MoAb Guy's 1 recognizes a carbohydrate and Guy's 13 a protein determinant and both MoAb prevented adherence of S. mutans; and (4) epitope specificity appears to be the most important factor in preventing adherence of S. mutans, as MoAb Guy's 11 and 13 share the same serotype specificity and both recognize a protein determinant, yet only Guy's 13 prevents colonisation. The long duration of protection from re-colonization by indigenous S. mutans, lasting about 1 year after application of the specific MoAb was stopped, cannot be accounted for by functional MoAb remaining on the teeth. We suggest that initially the MoAb prevents colonization by S. mutans and that the ecological niche vacated by this streptococcus is filled by other organisms from the oral flora, thereby discouraging re-colonization by S. mutans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478321      PMCID: PMC1542057     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  A preliminary report of long-term elimination of detectable mutans streptococci in man.

Authors:  H J Sandham; J Brown; H I Phillips; K H Chan
Journal:  J Dent Res       Date:  1988-01       Impact factor: 6.116

2.  Immunological and bacteriological basis for vaccination against dental caries in rhesus monkeys.

Authors:  T Lehner; S J Challacombe; J Caldwell
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

3.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION.

Authors:  J SILNESS; H LOE
Journal:  Acta Odontol Scand       Date:  1964-02       Impact factor: 2.331

Review 4.  Genetic analysis of Streptococcus mutans virulence.

Authors:  R Curtiss
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

5.  A biochemical scheme for the separation of the five varieties of Streptococcus mutans.

Authors:  I L Shklair; H J Keene
Journal:  Arch Oral Biol       Date:  1974-11       Impact factor: 2.633

6.  Immunization against dental caries.

Authors:  W H Bowen; B Cohen; M F Cole; G Colman
Journal:  Br Dent J       Date:  1975-07-15       Impact factor: 1.626

7.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans.

Authors:  S M Michalek; R L Gregory; C C Harmon; J Katz; G J Richardson; T Hilton; S J Filler; J R McGhee
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

9.  Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans.

Authors:  J K Ma; R Smith; T Lehner
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  Recognition of carbohydrate and protein epitopes by monoclonal antibodies to a cell wall antigen from Streptococcus mutans.

Authors:  C G Mitchell; R Smith; T Lehner
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more
  21 in total

1.  Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans.

Authors:  H Senpuku; T Iizima; Y Yamaguchi; S Nagata; Y Ueno; M Saito; N Hanada; T Nisizawa
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Authors:  Shizhen Zhang; Nicole M Green; Izabela Sitkiewicz; Rance B Lefebvre; James M Musser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Sequence and structural analysis of surface protein antigen I/II (SpaA) of Streptococcus sobrinus.

Authors:  R J LaPolla; J A Haron; C G Kelly; W R Taylor; C Bohart; M Hendricks; J P Pyati; R T Graff; J K Ma; T Lehner
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  Conservation of the gene encoding streptococcal antigen I/II in oral streptococci.

Authors:  J K Ma; C G Kelly; G Munro; R A Whiley; T Lehner
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

5.  T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II.

Authors:  C G Kelly; S Todryk; H L Kendal; G H Munro; T Lehner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

7.  Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule.

Authors:  L J Brady; D G Cvitkovitch; C M Geric; M N Addison; J C Joyce; P J Crowley; A S Bleiweis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 8.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

9.  Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405).

Authors:  H Senpuku; K Yanagi; T Nisizawa
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

10.  A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans.

Authors:  G H Munro; P Evans; S Todryk; P Buckett; C G Kelly; T Lehner
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.